Search peptides, terms, sources/
2 peptides

Brain and mood

Brain and mood peptides are studied for effects on memory, anxiety and recovery after stroke. The peptides here, Selank and Semax, were developed in Russia, and most of the evidence comes from animal studies and small human trials from a single research programme. Neither is licensed in the UK. Inclusion is not proof of benefit.

Which peptides are in this family?

  • SelankTP-7

    Synthetic tuftsin-derived peptide studied for anxiety. Not licensed in the UK; main human evidence is one active-comparator trial.

    Brain and moodHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • SemaxACTH heptapeptide analog

    Synthetic ACTH-derived peptide studied for brain function and stroke recovery. Not licensed in the UK; evidence is mainly rodent studies.

    Brain and moodHuman trialsEvidence reviewed
    LimitedNot licensed in the UK

Best recorded finding for each peptide in this family

Each row grades one recorded finding, not the peptide or the medicine.

PeptideUK statusFindingEvidence grade
SelankNot licensed in the UKAnxiety trial versus medazepamLimited
SemaxNot licensed in the UKAcute ischaemic stroke trialLimited

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.